// App-Quantinova.ai

4071 : Dexamethasone for the prevention of transcatheter arterial chemoembolization-induced fever, nausea, vomiting, and anorexia in patients with hepatocellular carcinoma: A randomized, double-blind, placebo-controlled trial.

Researchers

Presenter

  • Sadahisa Ogasawara

Principal Investigators

  • Tetsuhiro Chiba

  • Yoshihiko Ooka

  • Eiichiro Suzuki

  • Naoya Kanogawa

  • Tenyu Motoyama

  • Akinobu Tawada

  • Tomoo Nakagawa

  • Kazue Nagai

  • Hideki Hanaoka

  • Fumihiko Kanai

  • Osamu Yokosuka

Medical Centers

  • Department of Gastroenterology and Nephrology, Graduate School of Medicine, Chiba University, Chiba, Japan

  • Chiba University Graduate School of Medicine, Chiba City, Chiba, Japan

  • Clinical Research Centre, Chiba University Hospital, Chiba, Japan

  • Chiba University Hospital, Chiba, Japan

  • Department of Gastroenterology and Nephrology, Chiba University Hospital, Chiba, Japan

Locations

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Liver cancer

Biomarkers

  • N/A

Drug/Treatment

  • Dexamethasone

  • Dekpak 13 Day Taperpak

  • granisetron tablet

Outcome

  • N/A

Study Design

  • Randomized

  • Placebo Control

  • Double Blind/Blinded

  • Controlled

Phase

  • NA

Study Id's

  • UMIN000004317

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved